UK pharma boss, Dame Emma Walmsley says why GSK's (GlaxoSmithKline) priority is the USA Dame Emma Walmsley, Chief Executive one of Britain's biggest pharmaceutical companies GSK (GlaxoSmithKline), ...

This morning, GlaxoSmithKline announced a $3 billion criminal settlement with the Department of Justice to settle accusations that it didn't tell regulators about safety problems with an infamous drug ...

GlaxoSmithKline ( ($GB:GSK) ) has provided an update. GSK has announced that the US FDA approved Blujepa (gepotidacin), a new ...

GlaxoSmithKline ( ($GB:GSK) ) has shared an update. GlaxoSmithKline (GSK) has announced a transaction involving the purchase of 217,000 of its own ...

GlaxoSmithKline’s long-acting HIV drug cabotegravir is already challenging market leaders as part of an approved treatment regimen. Now, the medicine is a step closer to being a potential preventative ...

Pharmaceuticals firm GlaxoSmithKline (GSK) has improved its research and development (R&D) capabilities through a programme to enable the sharing of data generated through the development of medicines ...

UK drugs manufacturer GlaxoSmithKline has said it will not file patents for its products in the world's poorest nations. The step may make some important new medicines more affordable in the ...

When GlaxoSmithKline spins off its consumer health unit later this year, the British pharmaceutical giant’s standalone business will become Haleon—derived from the Old English word “Hale,” which means ...

GlaxoSmithKline has agreed to plead guilty and pay $3bn (£2bn; €2.4bn) in penalties for unlawful promotion of prescription drugs, failure to report safety data, and false price reporting. It also ...

Meesho’s Rs 5,421 crore IPO allotment will be finalised Monday after massive 81.76x subscription. With a 42% GMP and record retail participation, investors now await listing on December 10.

GlaxoSmithKline (GSK) has been accused of market "abuse" by the consumer watchdog, the Office of Fair Trading (OFT). The OFT alleges, external that the pharmaceutical giant paid rivals to delay the ...